|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Amortization of acquired intangible assets | |||||
| Litigation settlement - Note 16 | |||||
| Goodwill impairment - Note 5 | |||||
| Other operating expenses - Note 2 | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other expense: | |||||
| Interest expense | |||||
| Debt extinguishment and related costs | |||||
| Loss on pension settlement - Note 8 | |||||
| Loss on equity securities - Note 12 | |||||
| Other expense, net | |||||
| Total other expense | |||||
| Loss before income taxes | |||||
| Income tax (benefit) expense | |||||
| Net loss | |||||
| Loss per share: | |||||
| Basic and diluted loss per share (in dollars per share) | |||||
| Weighted-average common shares: | |||||
| Basic and diluted (in shares) | |||||
Loading...